{
  "meta": {
    "title": "Anterior_Pitutary_Hormones_Male_Female_Hormones_Serms_Antiandrogens_Aromatase_Inhibitors_Iodides_Bi",
    "url": "https://brainandscalpel.vercel.app/anterior-pitutary-hormones-male-female-hormones-serms-antiandrogens-aromatase-inhibitors-iodides-bi-7d9f00ed.html",
    "scrapedAt": "2025-11-30T08:50:47.575Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Octreotide</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Bromocriptine</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Promethazine</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old female patient presented to surgery department with complaints of galactorrhea. Her urine pregnancy test was negative. MRI of head revealed a large pituitary tumor. Patient refused to undergo surgery for the tumor. Which of the following is the best drug for the treatment of this patient?</span></p>",
      "unique_key": "DT1292837",
      "question_audio": null,
      "question_video": null,
      "map_id": 1292837,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>Prolactin is under predominant inhibitory control of hypothalamus through PRIH which is dopamine that acts </em><em>on the pituitary lactotroph D2 receptor.</em></p>\r\n<p><em><u>Dopaminergic agonists decrease plasma prolactin levels, hence can be used for hyperprolactinemia.</u></em></p>\r\n<ul>\r\n<li><strong><em>Dopamine, </em></strong></li>\r\n<li><strong><em>Bromocriptine, </em></strong></li>\r\n<li><strong><em>Cabergoline</em></strong></li>\r\n</ul>\r\n<p><em><u>Dopaminergic antagonists cause hyperprolactinemia</u></em></p>\r\n<ul>\r\n<li><em>Chlorpromazine</em></li>\r\n<li><em>Haloperidol</em></li>\r\n<li><em>Metoclopramide</em></li>\r\n<li><em>Dopamine depleter (reserpine)</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122302fef0be-154e-400e-a670-4111a1fa592a.jpg\"><br>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223a3843df1-cb7f-4341-beb4-ca5f4d6d53b3.jpg\">\r\n<p><strong>Option A</strong>: <em>Octreotide is a somatostatin analogue having high potency and long duration of action. It is preferred over somatostatin for all the indications</em>.</p>\r\n<p><strong>Option C</strong>: <em>Promethazine is a first generation antihistamine which has maximum penetration of blood-brain barrier and maximum anticholinergic activity.</em></p>\r\n<p><strong>Option D</strong>: <em>Clozapine is an atypical antipsychotic drug having weak D2 blocking action. It mainly acts by blocking 5-HT2, an adrenergic and D4 receptors. It suppresses both positive as well as negative symptoms (First FDA approved drug for antisuicide indication) of schizophrenia.</em></p>\r\n<p><strong><u>Key Takeaway: </u></strong></p>\r\n<ul>\r\n<li><strong><em>Dopaminergic agonists decrease plasma prolactin levels</em></strong><em>, hence can be used for hyperprolactinemia.</em></li>\r\n</ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethanolamine oleate</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Octreotide</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Phytonadione</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male patient with a history of hepatic cirrhosis brought to the emergency department with severe bouts of blood vomiting. On investigation he has portal hypertension due to hepatic cirrhosis and was diagnosed of having bleeding oesophageal varices. Which of the following agents should be immediately considered for treatment?</span></p>",
      "unique_key": "DT1293331",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293331,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em><u>Octreotide </u></em></strong></p>\r\n<ul>\r\n<li><em>This synthetic <u>octapeptide surrogate of somatostatin is 40 times more potent in suppressing GH secretion and longer acting</u>.</em></li>\r\n<li><em>It is <strong>preferred over somatostatin for acromegaly and secretory </strong></em><strong><em>diarrhoea associated with carcinoid, AIDS, cancer chemotherapy or diabetes.</em></strong></li>\r\n<li><em><u>Control of diarrhoea is due to suppression of hormones which enhance intestinal mucosal secretion</u></em><em>.</em></li>\r\n<li><em><u>Octreotide injected i.v. reduces hepatic blood flow and helps stop esophageal variceal bleeding.</u></em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223ab749707-4280-4faa-9b5d-063feb6d06d5.jpg\"><br>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412231062c34f-d7ce-490c-8532-315b1c7e47c7.jpg\">\r\n<p><strong>Option A, C &amp; D</strong>: <em>All other agents are not having effects over portal hypertension hence not used.</em></p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><em>Octreotide is a somatostatin analogue having a high potency and long duration of action. It is preferred over somatostatin for all the indications like <strong>acromegaly and secretory diarrhoea associated with carcinoid, AIDS, cancer chemotherapy or diabetes.</strong></em></li>\r\n</ul>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Bromocriptine</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Cabergoline</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Pegvisomant</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">L- thyroxine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old male patient presented to medicine department with coarse facial features, abnormally large hands, feet & jaw, deepened voice with large tongue (as given in the figure below) later diagnosed as having acromegaly. Which of the following parenteral drugs is effective for the treatment of the condition shown in the below image?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412238aac93df-e397-4ef6-87d9-63127b3dd8c3.jpg\"></span></p>",
      "unique_key": "DT1293335",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293335,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>The figure shows the features of acromegaly. </em></p>\r\n<p><strong><em>Dopamine agonists like bromocriptine and cabergoline are the only oral </em></strong><em>drugs for acromegaly.</em><em> <strong>Octreotide and pegvisomant are injectable</strong> drugs for acromegaly. </em></p>\r\n<p><strong><em>Pegvisomant : </em></strong></p>\r\n<ul>\r\n<li><em><u>Pegvisomant is a growth hormone receptor antagonist approved for the treatment of acromegaly</u></em><em>.</em></li>\r\n<li><em><u>Pegvisomant binds to the Growth hormone receptor but does not activate JAK-STAT signaling or stimulate IGF-1 secretion</u></em><em>.</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223f8783d70-9bd0-44d3-b9d8-4bf1f5ee2d5d.jpg\">\r\n<p><strong>Option A &amp; B: </strong><em>Dopamine agonists like bromocriptine and cabergoline are <strong>the only oral drugs for acromegaly.</strong></em></p>\r\n<p><strong>Option D: </strong><em>Main indication of thyroid hormones is hypothyroidism (<strong>cretinism, myxedema and myxedema coma</strong>). Levo-thyroxine (T4) is preferred for all these indications. </em></p>\r\n<p><strong><u>Key Takeaway: </u></strong></p>\r\n<ul>\r\n<li><em><u>Octreotide and pegvisomant</u></em><em> are injectable drugs for acromegaly.</em></li>\r\n</ul>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct effect of leuprolide on the endometrial implants</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Likely flare with increased gonadotropin effect prior to downregulation of receptors</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Probable placebo effect</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Resistance of her endometriosis to the leuprolide and probable need for another agent</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old woman brought to the gynaecology department with a history of having severe endometriosis with complaints of dysmenorrhea. She is treated with depot leuprolide acetate. One week after her first injection, she notes a marked increase in dysmenorrhea. Which of the following is the best explanation for the increase in dysmenorrhea following the first injection?</span></p>",
      "unique_key": "DT1293338",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293338,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>The initial <u>response to GnRH analog is an increase in FSH and estrogen, leading to an exacerbation of the endometriosis. </u></em></p>\r\n<p><em>Thereafter, <u>there is a downregulation of GnRH receptors of the pituitary, leading to a decrease in FSH and estrogen</u>.</em></p>\r\n<p><em><u>The frequency of administration of leuprolide determines its effect</u></em></p>\r\n<ul>\r\n<li><strong><em>Acute</em></strong><strong><em> administration will </em></strong><strong><em>increase</em></strong><strong><em> FSH/LH and sex steroids, </em></strong></li>\r\n<li><strong><em>Chronic</em></strong><strong><em> administration will </em></strong><strong><em>decrease</em></strong><strong><em> FSH/LH and sex steroids.</em></strong></li>\r\n</ul>\r\n<p><u>Chronic leuprolide administration leads to androgen blockade in men, which is useful in treating hormone-dependent cancers such as prostatic carcinoma.</u></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223a4f02084-164f-4902-87d7-5b8aacdefffe.jpg\">\r\n<p>Option A: Leuproilde doesn&rsquo;t act directly on Endometrial implant.</p>\r\n<p>Option C: Flare Up is due to Increased FSH and estrogen. So it&rsquo;s not a placebo effect.</p>\r\n<p>Option D: Resistance to drug will present with no changes in patient profile on administration of drug but Exacerbation suggests flare up reaction.</p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><strong><em>The initial response to GnRH analog is an increase in FSH and estrogen, leading to an exacerbation of the endometriosis.</em></strong></li>\r\n</ul>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Levonorgestrel tablet</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Injection DMPA</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral contraceptive pills</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 22-year-old female presents to obstetrics department just 8 hours after sexual assault. It is the 13th day of her menstrual cycle. Which of the following contraceptives should be prescribed to her?</span></p>",
      "unique_key": "DT1293340",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293340,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em>Emergency (postcoital) pill </em></strong></p>\r\n<p><em>These are for use in a woman not taking any contraceptive <u>who had a sexual intercourse risking unwanted pregnancy. </u></em></p>\r\n<p><em><u>Emergency postcoital contraception should be reserved for unexpected or accidental exposure (rape, condom rupture</u></em><em>) only, because all <u>emergency regimens have higher failure rate and side effects than regular low-dose combined pill. </u></em></p>\r\n<p><em><u>The most commonly used and standard regimen are as below: </u></em></p>\r\n<p><strong><em>Levonorgestrel </em></strong></p>\r\n<ul>\r\n<li><em>75 mg two doses 12 hours apart, or <u>1.5 mg single dose taken as soon as possible, but before 72 hours of unprotected intercourse</u>.</em></li>\r\n</ul>\r\n<p><strong><em>Ulipristal </em></strong></p>\r\n<ul>\r\n<li><em><u>30 mg single dose as soon as possible, but within 120 hours of intercourse.</u></em><em> It is an equally effective (failure rate 1-3% compared to levonorgestrel 2-4%) and equally well tolerated alternative method. </em></li>\r\n</ul>\r\n<p><strong><em>Mifepristone </em></strong></p>\r\n<ul>\r\n<li><em>600 mg single dose taken within 72 hours of intercourse.</em></li>\r\n</ul>\r\n<p>Option B: Inj DMPA 150 mg given every 3 monthly is implant contraceptive. Can't use it in emergency conditions.</p>\r\n<p>Option C: OCP Can't be used as emergency contraceptives.</p>\r\n<p>Option D: Misoprostol is used in Medical Abortion.</p>\r\n<p><strong><u>Key Takeaway :</u></strong></p>\r\n<ul>\r\n<li><em>Emergency postcoital contraception should be <strong>reserved for unexpected or accidental exposure (rape, condom rupture).</strong> The most commonly used agent is Levonorgestrel.</em></li>\r\n</ul>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Breast cancer</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoporosis</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Menopausal symptoms</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometriosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old woman is placed on a selective estrogen receptor modulator drug by her physician that has anti-estrogen effects on uterine and breast tissue but having estrogenic effects on bone. This drug is primarily used for which of the following indications?</span></p>",
      "unique_key": "DT1293343",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293343,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em>Raloxifene has antiestrogen effects on breast and uterine tissue, but estrogenic effects on bone, and it is used to prevent osteoporosis.</em></li>\r\n<li><em>It is not used to treat breast cancer, menopausal symptoms or endometriosis, or for contraception.</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122391dc4c1a-4bae-4dfe-86e6-d7f3e02e0733.jpg\">\r\n<p>Option A, C &amp; D: <em>It is not used to treat breast cancer, menopausal symptoms or endometriosis, or for contraception.</em></p>\r\n<p><strong><u>Key Takeaway: </u></strong></p>\r\n<ul>\r\n<li><em>Raloxifene has <strong>anti estrogen effects on breast and uterine tissue </strong>but estrogenic effects on bone, and it is used to prevent osteoporosis.</em></li>\r\n</ul>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Breast cancer</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial cancer</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Myocardial infarction</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Stroke</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old postmenopausal woman was brought to the gynaecology department with complaints of hot flushes, mood swings, lethargy etc. Her gynaecologist has prescribed hormone replacement (HRT) therapy to her. For prevention of which of the following adverse effects, progestin is included in regimens for HRT?</span></p>",
      "unique_key": "DT1293344",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293344,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>Postmenopausal women receiving HRT should receive a progestin for 10</em><em> to 13 days each month to <u>suppress endometrial hyperplasia that would otherwise be produced by unopposed estrogen therapy</u>. </em></p>\r\n<p><em>Progestins are <strong>added to decrease the risk of endometrial and ovarian</strong></em><strong><em> carcinoma. </em></strong><em>A <u>progestin is not required in women who have had a hysterectomy</u>. </em></p>\r\n<p><em>Major indications of progesterone are for <strong>oral contraception </strong>and <strong>hormone replacement therapy, </strong>for which these are combined with estrogens.</em></p>\r\n<p><strong><em>Inclusion of a progestin will not prevent </em></strong></p>\r\n<ul>\r\n<li><em><u>breast cancer</u></em></li>\r\n<li><em><u>myocardial infarction</u></em></li>\r\n<li><em><u>stroke</u></em></li>\r\n<li><em><u>Though the progestin may attenuate the metabolic and cardiovascular benefits of estrogen, it is <strong>needed to block the increased risk of dysfunctional uterine bleeding and endometrial carcinoma due to continuous estrogenic stimulation of endometrium</strong></u></em><strong><em>.</em></strong></li>\r\n</ul>\r\n<p>Option A: <strong><em>Inclusion of a progestin will not prevent breast cancer because it's both estrogen and progesterone dependent cancer.</em></strong></p>\r\n<p>Option C: <strong><em>Inclusion of a progestin will not prevent Risk of MI. Instead increase risk due to increased Thromboembolism.</em></strong></p>\r\n<p>Option D: <strong><em>Inclusion of a progestin will not prevent stroke. Instead, increase risk due to increased thromboembolism.</em></strong></p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><strong><em>Progestins are added to the HRT to decrease the risk of endometrial and ovarian carcinoma.</em></strong></li>\r\n</ul>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma in opposite breast</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Endometrial hyperplasia</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian carcinoma</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic myeloid leukemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old female presented to the gynaecology department seeking treatment for unilateral breast cancer. Later she was put on tamoxifen therapy for the cancer by her surgeon. Which of the following is the most serious adverse effect often associated with the use of tamoxifen?</span></p>",
      "unique_key": "DT1293347",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293347,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>Tamoxifen is a <u>SERM that acts as an antagonist at estrogen receptors in the breast but agonist at uterus hence, it can cause endometrial hyperplasia</u>.</em></p>\r\n<p><em>It <u>decreases the risk of contralateral breast cancer and is Approved for primary prevention of breast cancer in women at high</u> risk.</em></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223857992ec-cec9-4e7c-a9b0-cc62abbed665.jpg\">\r\n<p>Option A: <em>It decreases the risk of contralateral breast cancer and is Approved for primary prevention of breast cancer in women at high risk.</em></p>\r\n<p>Option C &amp; D: tamoxifen use isn&rsquo;t associated with Ovarian carcinoma &amp; CML.</p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><em>Tamoxifen is a SERM that acts as an antagonist at estrogen receptors in the breast but agonist at the uterus hence it can cause endometrial hyperplasia.</em></li>\r\n</ul>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Conjugated estrogens</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Levonorgestrel</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Raloxifene</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitriol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 49-year-old woman complains of sweating profusely nearly every night. She had a transvaginal hysterectomy 5 years ago but has intact ovaries. Upon physical examination, you note that she has a BMI of 22, but all her vital signs are normal. Which of the following would best treat her condition?</span></p>",
      "unique_key": "DT1293351",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293351,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em><u>Vasomotor symptoms are the most common complaint of perimenopausal women</u></em><em>. </em></p>\r\n<p><em><u>Estrogen is the only effective treatment of these symptoms. Since there is no concern of endometrial cancer, a progestin is not indicated</u></em><em>. </em></p>\r\n<p><u>Currently, the two most common uses of estrogens are as <em>contraceptives </em>and for <em>hormone replacement</em> <em>therapy </em>(HRT) in postmenopausal women</u></p>\r\n<p><strong><em><u>Hormone replacement therapy (HRT): </u></em></strong></p>\r\n<p>Due to cessation of ovarian function at menopause, women suffer a number of physical, psychological and emotional consequences.</p>\r\n<p>Medical problems related to menopause are:</p>\r\n<p><strong><em>Vasomotor disturbances </em></strong></p>\r\n<ul>\r\n<li>Hot flashes, chilly sensation, inappropriate sweating, faintness, paresthesias, aches and pains.</li>\r\n</ul>\r\n<p><strong><em>Urogenital atrophy </em></strong></p>\r\n<ul>\r\n<li>Change in vaginal cytology and pH, vaginal dryness, vulval shrinkage, dyspareunia, vaginitis, itching, urinary urgency, predisposition to urinary tract infection.</li>\r\n</ul>\r\n<p><strong><em>Osteoporosis </em></strong></p>\r\n<ul>\r\n<li>Loss of osteoid as well as calcium &rarr; thinning and weakening of bone &rarr; minimal trauma fractures, especially of femur, hip, radius, vertebrae.</li>\r\n</ul>\r\n<p><strong><em>Dermatological changes </em></strong></p>\r\n<ul>\r\n<li>Thinning, drying and loss of elasticity of skin, wrinkles, thin and listless hairs.</li>\r\n</ul>\r\n<p><strong><em>Psychological/Cognitive disturbances </em></strong></p>\r\n<ul>\r\n<li>Irritability, depressed mood, loss of libido and self confidence, anxiety and dementia.</li>\r\n</ul>\r\n<p><strong><em>Increased risk of cardiovascular diseases </em></strong></p>\r\n<ul>\r\n<li>Coronary artery disease, myocardial infarction, stroke.</li>\r\n</ul>\r\n<p><strong>Option B : </strong><em><u>Estrogen &plusmn; progestin HRT or \"menopausal hormone therapy\" (MHT) is highly efficacious in suppressing the perimenopausal syndrome of vasomotor instability, psychological disturbances as well as in preventing atrophic changes and osteoporosis. However, progesterone alone is not effective.</u></em></p>\r\n<p><strong>Option C</strong>: Raloxifene makes hot flashes worse.</p>\r\n<p><strong>Option D</strong>: Vitamin D analogue might help maintain Ca<sup>2+</sup>, it would not have any effect on the vasomotor symptoms.</p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><em>Vasomotor symptoms are the most common complaint of perimenopausal Hence, it can be treated by conjugated estrogen in patients with hysterectomy.</em></li>\r\n</ul>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">It has estrogen agonist effect of the breast and uterus, thereby leading to endometrial hyperplasia.</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">It is an estrogen antagonist in the breast and uterus, leading to loss of endometrial cells.</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">It has an antagonist effect on the breast but an agonist effect on the uterus.</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">It has no effect on the uterus, and the vaginal bleeding is caused by something else.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old woman was prescribed tamoxifen by her gynaecologist for breast cancer. She again reported to the gynaecology department with fresh complaints of vaginal bleeding after taking tamoxifen. Which of the following is the best explanation regarding the same?</span></p>",
      "unique_key": "DT1293354",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293354,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em><u>Tamoxifen has an estrogen antagonist effect on the breast but a weak agonist effect on the uterus, leading to endometrial hyperplasia in some women, likely cause of vaginal bleeding.</u></em></li>\r\n<li><em><u>Endometrial cancer is seen in some patients.</u></em></li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223857992ec-cec9-4e7c-a9b0-cc62abbed665.jpg\">\r\n<p><strong><u>Option A, B &amp; D: </u></strong></p>\r\n<p><strong>Tamoxifen effects: </strong></p>\r\n<p><strong>Uterus - Agonist - Endometrial hyperplasia </strong></p>\r\n<p><strong>Breast - Antagonist - Used in Breast Ca. </strong></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Tamoxifen has an estrogen antagonist effect on the breast but a weak agonist effect on the uterus, leading to endometrial hyperplasia in some women, likely cause of vaginal bleeding.</em></li>\r\n</ul>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) release</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of gonadotropin-releasing hormone (GnRH) release</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of 5&alpha; -reductase enzyme</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Blockade of progesterone receptors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old man with a long history of chronic cardiac failure presented to his physician complaining of urinary hesitancy and frequent need to urinate during the night. An examination revealed an enlarged prostate, and further examination confirmed the diagnosis of benign prostatic hyperplasia. Finasteride was included as part of his therapeutic regimen. Which of the following actions most likely mediated the therapeutic effect of the drug in the patient's disease?</span></p>",
      "unique_key": "DT1293414",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293414,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em><u>Finasteride is a competitive inhibitor of 5&alpha;-reductase, the enzyme that converts testosterone to dihydrotestosterone</u></em><em>.</em></li>\r\n<li><em>Dihydrotestosterone is the principal androgen responsible for stimulation of prostatic growth.</em></li>\r\n<li><em>The definitive therapy of benign prostatic hyperplasia is surgical, but drugs can be used when surgery is contraindicated, as in this case.</em></li>\r\n<li><em><u>5 &alpha; reductase converts testosterone into Dihydrotestosterone (DHT) which works on androgen receptors</u></em><em>.</em></li>\r\n<li><em>Testosterone also can directly work on androgen receptors.</em></li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223bb688d3f-e483-4c1a-90c6-f3814ce6b8c2.jpg\">\r\n<p><strong>5-</strong>&alpha; <strong>reductase inhibitors: </strong></p>\r\n<p>Most of the actions of testosterone are mediated by its conversion to DHT by 5-&alpha; reductase.</p>\r\n<p><strong>Finasteride and dutasteride </strong>are <u>5-&alpha; reductase inhibitors useful in the <em>treatment of BHP, male pattern baldness and hirsutism </em>by reducing the production of DHT.</u></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122378ad8cd2-32dc-49a8-8cf5-e3eac8ddd890.jpg\">\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Finasteride is a competitive inhibitor of 5&alpha;-reductase, the enzyme that converts testosterone to dihydrotestosterone. Hence suppressing and partially reversing prostatic hyperplasia</em></li>\r\n</ul>",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Breast tenderness</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Alopecia</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Hot flashes</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Deep vein thrombosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old man was taking a nonsteroidal drug without any prescription. The drug was supposedly acting via competing with testosterone for its binding sites. Which of the following adverse effect is most likely to occur in persons taking this drug?</span></p>",
      "unique_key": "DT1293417",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293417,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em><u>Bicalutamide, flutamide, and nilutamide are androgen receptor antagonists</u></em><em> that <u>prevent feedback inhibition of hypothalamic GnRH secretion in men, leading to hot flashes</u>.</em></li>\r\n<li><em>These drugs are <u>usually given for metastatic carcinoma of prostate as a component of combined androgen blockade therapy</u>.</em></li>\r\n<li><em>When used along with a GnRH agonist or castration, they afford marked</em><em> relief in bone pain and other symptoms due to the metastasis</em>.</li>\r\n</ul>\r\n<p><strong><em>Side effects are </em></strong></p>\r\n<ul>\r\n<li><strong><em><u>Hot flashes </u></em></strong></li>\r\n<li><em>Chills, </em></li>\r\n<li><em>Edema and loose stools, </em></li>\r\n<li><em>Elevation of hepatic transaminase</em></li>\r\n</ul>\r\n<p>Option A , B &amp; D: Breast tenseness, Alopecia and DVT are not associated with anti androgen use.</p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Androgen receptor antagonists prevent feedback inhibition of hypothalamic GnRH secretion in men, leading to hot flashes.</em></li>\r\n</ul>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Anastrozole</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Danazol</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Leuprolide</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Fulvestrant</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 54-year-old woman was admitted to the hospital because of increasing shortness of breath. Five years earlier, the woman had been diagnosed with hormone-positive breast cancer and underwent radical mastectomy and six cycles of chemotherapy. She had been receiving hormonal therapy with tamoxifen since then. A computed tomography scan showed multiple lung metastases. Tamoxifen was stopped, and a therapy with a competitive estrogen receptor antagonist was initiated. Which of the following drugs was most likely given?</span></p>",
      "unique_key": "DT1293421",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293421,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em>Hormonal therapy in the metastatic breast cancer setting can provide long progression-free survival in patients.</em></li>\r\n<li><em>Because the patient was well controlled with tamoxifen for 5 years, another hormonal agent is a reasonable choice.</em></li>\r\n<li><em><u>Fulvestrant, a competitive estrogen receptor antagonist, has been approved for patients who have become resistant to tamoxifen, as in this case.</u></em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223409014f3-626f-4787-83c5-d76c826b1f5e.jpg\">\r\n<p><strong>Option A: </strong><em>Aromatase is an enzyme responsible for the conversion of androstenedione (an androgen precursor) to estrone (estrogenic hormone). </em></p>\r\n<p><em>Drugs inhibiting aromatase include aminoglutethimide, anastrozole, exemestane and letrozole. Aromatase inhibitors are useful in advanced breast carcinoma. Adverse effects include hot flushes, arthralgia and fatigue.</em></p>\r\n<p><strong>Option B: </strong><em>Danazol is a compound with weak androgenic, progestational and glucocorticoid activities. It decreases the secretion of gonadotropins from the pituitary by causing feedback inhibition. Its major use is in the treatment of endometriosis.</em></p>\r\n<p><strong>Option C: </strong><em>Gonadotropin releasing hormone agonists like leuprolide and goserelin are useful for the treatment of advanced prostate cancer.</em></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Fulvestrant, a competitive estrogen receptor antagonist, has been approved for patients who have become resistant to tamoxifen.</em></li>\r\n</ul>",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Aldosterone</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Progestin</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadotropin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old woman with child bearing potential is placed on a contraceptive by her gynaecologist that lowers her blood pressure and at the same time it does not cause acne. Receptors for which of the following hormones are blocked by this drug?</span></p>",
      "unique_key": "DT1293424",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293424,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><em><u>Drospirenone is a progestin that antagonizes androgen and aldosterone receptors.</u></em></li>\r\n<li><em>It <u>lowers blood pressure by decreasing salt and water retention, but it does not block estrogen, progestin, gonadotropin, or glucocorticoid receptors.</u></em></li>\r\n<li><em>The spironolactone derivative <u>drospirenone may have advantageous effects on the cardiovascular system due to its antiandrogenic and antimineralocorticoid activities.</u></em></li>\r\n<li><strong><em>Drospirenone/</em></strong><strong><em>Ethinyl estradiol combination is used in female acne.</em></strong></li>\r\n</ul>\r\n<p><strong><em>Option B, C &amp; D: </em></strong>Estrogen, Progestin &amp; Gonadotropin <em>All these agents don&rsquo;t block aldosterone receptors. </em></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Drospirenone (spironolactone derivative) is a progestin that antagonizes androgen and aldosterone receptors.</em></li>\r\n</ul>",
      "correct_choice_id": 131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of iodination of tyrosine residues</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulation of thyroid peroxidase</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Blockade of iodine uptake by the thyroid gland</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Accumulation of iodine into thyroglobulin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man complained to his physician of increased appetite, palpitations and diarrhea. Laboratory results confirmed the diagnosis of mild hyperthyroidism, and a treatment with methimazole was started. Which of the following actions most likely contributed to the therapeutic efficacy of the drug in this patient?</span></p>",
      "unique_key": "DT1293428",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293428,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>Methimazole and propylthiouracil are thioamides used as antithyroid agents. </em></p>\r\n<p><em><u>These drugs inhibit thyroid peroxidase</u></em><em>, the enzyme that catalyzes the following three steps in thyroid hormone biosynthesis:</em></p>\r\n<ul>\r\n<li><strong><em><u>Oxidation</u></em></strong><em><u> of iodide to iodine</u></em></li>\r\n<li><strong><em><u>Iodination</u></em></strong><em><u> of tyrosine residues within thyroglobulin </u></em></li>\r\n<li><strong><em><u>Combination</u></em></strong><em><u> of two diiodotyrosines (DITs), leading to T4, and combination of monoiodotyrosine (MIT) and DIT, which leads to T3.</u></em></li>\r\n</ul>\r\n<p><strong><em>By blocking the enzyme, the synthesis of thyroid hormones is blocked.</em></strong></p>\r\n<ul>\r\n<li><em>Thioamides bind to the thyroid peroxidise and prevent oxidation of iodide and iodotyrosyl residues, thereby;</em></li>\r\n<li><strong><em><u>Inhibit iodination of tyrosine residues in thyroglobulin</u></em></strong></li>\r\n<li><strong><em><u>Inhibit coupling of iodotyrosine residues to form T3 and T4.</u></em></strong></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412237af7b7ea-5e1e-4e3a-9eb9-d0ef25350b2d.jpg\"><br>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412231830ecbf-7d1c-4ed1-8f52-d597d2ee1f34.jpg\">\r\n<p><strong>Option B: </strong>Methimazole <strong>inhibits</strong> Thyroid Peroxidase.</p>\r\n<p><strong>Option C: </strong> <strong>Ionic inhibitors</strong> cause blockade of iodine uptake by the thyroid gland.</p>\r\n<p><strong>Option D: Iodine &amp; Iodides inhibit release of hormone so it causes </strong>Accumulation of iodine into thyroglobulin.</p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><em>Thioamides bind to the thyroid peroxidase and prevent oxidation of iodide and iodine tyrosyl residues.</em></li>\r\n</ul>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Measure T3, T4 and TSH after one month</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Start L-thyroxine (T4) treatment 100 mcg once daily</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Start L-thyroxine (T4) treatment 25 mcg daily and gradually increase</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Start daily L-thyroxine (T4) 100 mcg with Liothyronine (T3) 5 mcg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female presented with weight gain and cold intolerance. On investigations Value of T3 is 70 ng/dl, T4 is 3 mcg/dl and TSH is 20 mIU/L. Which of the following statements is correct regarding the management of this patient?</span></p>",
      "unique_key": "DT1293433",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293433,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><em>Adult hypothyroidism (Myxoedema)</em></strong></p>\r\n<p><em><u>Antibodies against thyroid peroxidise or thyroglobulin are responsible for majority of cases of adult hypothyroidism</u></em><em>. </em></p>\r\n<p><em><u>Important drugs that can cause hypothyroidism</u></em><em> are </em></p>\r\n<ul>\r\n<li><strong><em><sup>131</sup></em></strong><strong><em>i</em></strong></li>\r\n<li><strong><em>Iodides</em></strong></li>\r\n<li><strong><em>Lithium </em></strong></li>\r\n<li><strong><em>Amiodarone</em></strong></li>\r\n<li><strong><em>Treatment with T4 is most gratifying.</em></strong></li>\r\n</ul>\r\n<ul>\r\n<li><em><u>It is wise to start with a lower dose (25-50 &mu;g/day), while in the elderly or in those with heart disease, the initial dose should be 12.5-25 &mu;g/day</u></em><em>.</em></li>\r\n<li><em>Doses may be increased every 2-3 weeks to an optimum of 100-150 &mu;g/day (adjusted by clinical response as well as serum TSH and free T4 levels).</em></li>\r\n<li><em><u>Individualization of proper dose is critical, aiming at normalization of serum TSH levels. Increase in dose is mostly needed during pregnancy</u></em><em>.</em></li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122370bb86c7-4ad2-41d0-8b48-7d0ac3b0908a.jpg\"><br>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412232c821877-25a5-43f2-8f5a-df7a99521e3a.jpg\">\r\n<p>Option A: Measurement of T3, T4 and TSH is done every 2-3 weeks to Check Response and Dose Upgradation.</p>\r\n<p>Option B: Start daily L-thyroxine (T4) 100 mcg daily is incorrect because it started at a lower dose of 25 mcg.</p>\r\n<p>Option D: Start daily L-thyroxine (T4) 100 mcg with Liothyronine (T3) 5 mcg is incorrect because it started at a lower dose of 25 mcg.</p>\r\n<p><strong><u>Key Takeaway :</u></strong></p>\r\n<ul>\r\n<li><em>It is wise to <strong>start with a lower dose (25-50 &mu;g/day).</strong> Doses may be increased every 2-3 weeks to an <strong>optimum of 100-150 &mu;g/day </strong>(adjusted by clinical response as well as serum TSH and free T4 levels).</em></li>\r\n</ul>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrointestinal bleeding</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Thromboembolism</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Agranulocytosis</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old woman presented to the medicine department with complaints of weight loss, nervousness, heat intolerance and exophthalmos. She was prescribed a thioamide group of medicine that may induce a remission in her disease. Which of the following serious adverse effects has been associated with this medication?</span></p>",
      "unique_key": "DT1293435",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293435,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em><u>Thioamide drugs are associated with leukopenia and, rarely, agranulocytosis</u></em><em>, and patients should be carefully monitored for these conditions. </em></p>\r\n<p><strong>Adverse effects </strong></p>\r\n<ul>\r\n<li><strong><em>Hypothyroidism and goiter </em></strong><em>[<u>Enlargement of thyroid is an indication of hypothyroidism and is due to excess feedback TSH production</u>]</em></li>\r\n<li><strong><em>Gastrointestinal Intolerance </em></strong></li>\r\n<li><strong><em>Skin rashes </em></strong></li>\r\n<li><em>Joint pain</em></li>\r\n<li><strong><em>Liver damage</em></strong><em> can occur [especially with propylthiouracil]</em></li>\r\n<li><em>Loss or graying of hair</em></li>\r\n<li><em>Loss of taste and fever [infrequent]</em></li>\r\n<li><strong><em><u>Agranulocytosis [Rare but serious adverse effect]</u></em></strong></li>\r\n</ul>\r\n<p><strong>Option A, B &amp; D :</strong> Thioamide are not associated with GI Bleeding, Thromboembolism and Liver failure.</p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><em>Thioamide drugs are associated <strong>with leukopenia and, rarely, agranulocytosis.</strong></em></li>\r\n</ul>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Long-term corticosteroid therapy</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol therapy</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioactive iodine</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Surgical resection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-year-old man is noted to have tachycardia, heat intolerance, weight loss, and an enlarged thyroid gland. Which of the following is the probable ultimate permanent treatment for this patient?</span></p>",
      "unique_key": "DT1293449",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293449,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>This patient likely has <u>Graves disease, the most common cause of hyperthyroidism, typically presenting with a painless goiter and symptoms of hyperthyroidism</u>. </em></p>\r\n<p><em>The <u>treatment of choice is radioactive iodine</u>. </em></p>\r\n<p><em><u><sup>131</sup></u></em><em><u>I is the treatment of choice after 25 years of age and if CHF, angina or any other contraindication to surgery is present</u></em><em>.</em></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223bbecb1bc-4db0-4629-92f9-3131bd9fa14d.jpg\">\r\n<p><strong>Option A</strong>: <em>Steroids (i.v. methylprednisolone) are used for Graves's </em><em>opthalmopathy.</em></p>\r\n<p><strong>Option B</strong>: <em>&beta;-blockers (propranolol, esmolol, atenolol) antagonize the sympathetic effects of thyrotoxicosis like tremors, tachycardia, palpitations and anxiety. <strong><u>Beta blockers are drugs of choice for thyroid storms.</u></strong></em></p>\r\n<p><strong>Option D</strong><em>: Surgical resection comes with some side effects like permanent risk of hypothyroidism, nerve damage etc. which is preferred in young patients to avoid permanent hypothyroidism post radioiodine ablation. </em></p>\r\n<p><strong><u>Key Takeaway: </u></strong></p>\r\n<ul>\r\n<li><em><sup>131</sup></em><em>I is the treatment of choice after 25 years of age <strong>and if CHF, angina, or any other contraindication to surgery is present.</strong></em></li>\r\n</ul>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Agranulocytosis</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Aplasia anemia</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver toxicity</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Lung fibrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female patient diagnosed of having hyperthyroidism was put on Propylthiouracil by her physician. Which of the following side effects is least likely to occur to this patient by taking this thioamide group of medicine? </span></p>",
      "unique_key": "DT1293454",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293454,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>Thioamides include drugs like methimazole, carbimazole and propylthiouracil.</em></p>\r\n<p><em><u>Agranulocytosis and aplastic anemia is a serious side effect of all of these drugs but it is seen rarely. (<strong>Option A &amp; B)</strong></u></em></p>\r\n<p><em><u>Lung fibrosis is not at all associated with use of the same drugs. <strong>Which is seen with Amiodarone. (Option D) </strong></u></em></p>\r\n<p><em>Propylthiouracil is associated with hepatotoxicity. (<strong>Option C)</strong>. All <u>the 3 drugs are teratogenic. Least teratogenic is propylthiouracil</u>.</em></p>\r\n<p><strong><em><u>Adverse effects of Thioamides</u></em></strong></p>\r\n<ul>\r\n<li><strong><em>Hypothyroidism and goiter </em></strong><em>[<u>Enlargement of thyroid is an indication of hypothyroidism and is due to excess feedback TSH production</u>]</em></li>\r\n<li><strong><em>Gastrointestinal Intolerance </em></strong></li>\r\n<li><strong><em>Skin rashes </em></strong></li>\r\n<li><em>Joint pain</em></li>\r\n<li><strong><em>Liver damage</em></strong><em> can occur [especially with propylthiouracil]</em></li>\r\n<li><em>Loss or graying of hair</em></li>\r\n<li><em>Loss of taste and fever [infrequent]</em></li>\r\n<li><strong><em><u>Agranulocytosis [Rare but serious adverse effect]</u></em></strong></li>\r\n</ul>\r\n<p>Option A: PTU Can Cause Agranulocytosis as a Rare Side effect.</p>\r\n<p>Option B: PTU Can Cause Aplastic anemia as a Rare Side effect.</p>\r\n<p>Option C: PTU Is highest hepatotoxic among all thioamides.</p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><em>Thioamide drugs are associated with leukopenia and, rarely, agranulocytosis</em></li>\r\n</ul>",
      "correct_choice_id": 184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Methimazole</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium iodide</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Levothyroxine</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Radioactive iodine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old woman complained to her physician of fatigue, constipation, and menstrual irregularities for the past 2 months. Physical examination showed delayed deep tendon reflexes, mild bradycardia and a nontender, nodular thyroid goiter. A blood analysis showed a very high level of thyroid peroxidise antibodies of 120 IU/L. Which of the following drugs would be most appropriate for this patient?</span></p>",
      "unique_key": "DT1293460",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293460,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>The <u>patient&rsquo;s signs and symptoms indicate that she was most likely suffering from hypothyroidism</u> and lab results confirmed that the disorder was due to Hashimoto thyroiditis. </em></p>\r\n<p><em>In most <u>cases, high levels of antibodies to thyroid peroxidase are diagnostic for this disease</u>. </em></p>\r\n<p><em>Hashimoto thyroiditis is likely the most common cause of hypothyroidism. </em></p>\r\n<p><em>The <u>treatment usually requires lifelong replacement therapy with thyroid hormones.</u></em></p>\r\n<p><em>The <strong>most important use of thyroid hormone is for replacement therapy in deficiency states.</strong></em></p>\r\n<p><strong>Synthetic l-thyroxine is the preparation of choice for following: </strong></p>\r\n<ol>\r\n<li><strong> <em>Cretinism</em></strong>\r\n<ul>\r\n<li><em><u>Treatment with thyroxine (8-12 &mu;g/kg) daily should be started as early as possible, because mental retardation that has already ensued is only partially reversible</u></em><em>.</em></li>\r\n</ul>\r\n</li>\r\n<li><strong><em> Adult hypothyroidism (Myxoedema) &amp; Subclinical hypothyroidism </em></strong>\r\n<ul>\r\n<li><em><u>It is wise to start with a lower dose (25-50 &mu;g/day), while in the elderly or in those with heart disease, the initial dose should be 12.5-25 &mu;g/day</u></em><em>. </em></li>\r\n<li><em>Doses may be increased every 2-3 weeks to an optimum of 100-150 &mu;g/day (adjusted by clinical response as well as serum TSH and free T4 levels). </em></li>\r\n</ul>\r\n</li>\r\n<li><strong> <em>Myxoedema coma </em></strong></li>\r\n<li><strong> <em>Nontoxic goiter </em></strong></li>\r\n<li><strong> <em>Thyroid nodule </em></strong></li>\r\n<li><strong> <em>Papillary carcinoma of thyroid </em></strong></li>\r\n<li><strong> <em>Empirical uses </em></strong></li>\r\n</ol>\r\n<p>T4 has been sometimes used in the following conditions without any rationale; response is unpredictable.</p>\r\n<ul>\r\n<li><em>Refractory anaemias.</em></li>\r\n<li><em>Mental depression.</em></li>\r\n<li><em>Menstrual disorders, infertility not corrected by usual treatment.</em></li>\r\n<li><em>Chronic/non-healing ulcers.</em></li>\r\n<li><em>Obstinate constipation.</em></li>\r\n</ul>\r\n<p><strong>Option A: </strong><em>Thyroid peroxidase inhibitors are used for the control of <strong>thyrotoxicosis</strong> in patients with Graves&rsquo; disease and toxic nodular goiter.</em></p>\r\n<p><strong>Option B: </strong><em>Sodium iodide, potassium iodide and Lugol&rsquo;s solution (5% iodine in 10% KI) act as \"thyroid constipating agents\" by inhibiting the release of T3 and T4. These drugs are the <strong>fastest acting anti-thyroid drugs.</strong></em></p>\r\n<p><strong>Option D</strong>: <em><sup>131</sup>I is the <strong>treatment of choice for hyperthyroidism </strong>after 25 years of age and if CHF, angina or any other contraindication to surgery is present.</em></p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><em>The most important use of thyroid hormone is for replacement therapy in deficiency states.</em></li>\r\n</ul>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonates</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitonin</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous estrogen therapy</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Saline infusion and furosemide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 53-year-old woman who is being treated for metastatic breast cancer is noted to have some lethargy, fatigue and an elevated serum calcium level. She is brought into the emergency department for a near comatose state, thought to be caused by the hypercalcemia. After addressing the airway, breathing, circulation, which of the following is the immediate best therapy for this patient?</span></p>",
      "unique_key": "DT1293462",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293462,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>Loop diuretics, given with IV normal saline, are the best choice in a patient with acute-onset hypercalcemia. </em></p>\r\n<p><strong><em>Hypercalcaemia of malignancy: </em></strong></p>\r\n<ul>\r\n<li><em><u>Severe hypercalcaemia, a common complication of malignancy, is a medical emergency with dehydration and altered consciousness</u></em><em>.</em></li>\r\n<li><strong>Rapid rehydration with i.v. Saline infusion is the first step, which itself lowers serum Ca2+ to some extent.</strong></li>\r\n<li><strong><em>Pamidronate or zoledronate are the most effective drugs, but take 24&ndash;48 hours to act.</em></strong></li>\r\n<li><em>They may be <strong><u>supplemented by calcitonin</u></strong> to achieve rapid action.</em></li>\r\n<li><em><u>Vigorous i.v. hydration is instituted first. After volume repletion, <strong>furosemide is added to enhance Ca2+ excretion and to prevent volume overload</strong></u></em><strong><em>.</em></strong></li>\r\n<li><em>This is <u>followed by <strong>BPN infusion.</strong> This therapy reduces serum calcium within few hours and corrects the attending dehydration</u>.</em></li>\r\n</ul><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412239d9abae2-4872-4f35-af33-fcd359772452.jpg\">\r\n<p>Option A: Bisphosphonate are the most effective drugs but the most immediate step is IV Saline to Correct Dehydration and AMS.</p>\r\n<p>Option B: Calcitonin is given after initial stabilisation with Iv Saline, Lasix &amp; Bisphosphonate usage.</p>\r\n<p>Option C: IV Estrogen Therapy has no role in management of Hypercalcemia.</p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><em>Severe hypercalcaemia is a medical emergency with dehydration and altered consciousness. <strong>Rapid rehydration with i.v. saline infusion is the primary therapy of choice.</strong></em></li>\r\n</ul>",
      "correct_choice_id": 204,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium requirement is 1200 mg per day</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral vitamin D3 should be given along with calcium supplements</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonates therapy should not be repeated for more than one year</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Teriparatide therapy should be followed by bisphosphonate therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old postmenopausal woman having a previous history of hip fracture presented to the orthopaedic department with lower backache. Later on investigation (DEXA scan) she was diagnosed of having osteoporosis. Which of the following statements is false regarding drugs for osteoporosis in this patient? </span></p>",
      "unique_key": "DT1293464",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293464,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>Bisphosphonates should be <strong>at least given for at least 5 years</strong> and it continues to afford protection for at least 5 years of continuous use</em>.</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223ad6eeda9-730a-4ec3-a831-f0547d100803.jpg\">\r\n<p><strong><em>Osteoporosis </em></strong></p>\r\n<ul>\r\n<li><em>The second and third generation BPNs (e.g. alendronate, ibandronate, risedronate) are effective in</em>\r\n<ul>\r\n<li><em><u>Preventing and treating postmenopausal osteoporosis in women</u></em></li>\r\n<li><em><u>Age related, idiopathic and steroid induced osteoporosis in both men and women.</u></em></li>\r\n</ul>\r\n</li>\r\n<li><em>Alendronate is equally or more effective than HRT or raloxifene in conserving bone mineral density.</em></li>\r\n<li><em>Bisphosphonates are more effective than calcitonin and continue to afford protection for at least 5 years of continuous use. Thus, they are the first choice drugs now for osteoporosis.</em></li>\r\n<li><em>Since the t&frac12; of alendronate in bone is ~ 10 years, treatment beyond 5 years is considered unnecessary.</em></li>\r\n</ul>\r\n<p>Option A: Calcium daily requirement in Postmenopausal females is 1200 mg. So Option A is correct.</p>\r\n<p>Option B: Oral vitamin D3 should be given along with calcium supplements due to increased requirements.</p>\r\n<p>Option D: Teriparatide which works by Stimulating Bone formation, is given after Bisphosphonate therapy.</p>\r\n<p><strong><u>Key Takeaway : </u></strong></p>\r\n<ul>\r\n<li><strong><em>Bisphosphonates should be given for at least 5 years </em></strong><em>and it continues to afford protection for at least 5 years of continuous use. </em></li>\r\n</ul>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitonin</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Dihydrotachysterol</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Denosumab</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Infliximab</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A postmenopausal woman with a family history of osteoporosis completed a bone mineral density work-up and found out having osteoporosis. She tried a short course of teriparatide a year ago but complained of serious depression and mood changes. Her physician prescribed an antibody-based therapy. Which of the following is the drug the physician has prescribed?</span></p>",
      "unique_key": "DT1293468",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293468,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>Denosumab is an antibody against RANK ligand. </em></p>\r\n<p><em>It <u>blocks proliferation and activation of osteoclasts and is administered every 6 months by subcutaneous injection.</u></em></p>\r\n<p><em>On the surface of osteoclast cells, RANK receptors are present. When ligand binds to RANK receptors, it stimulates the resorption of bone.</em></p>\r\n<p><em><u>Denosumab is a monoclonal antibody against RANK ligand. It inhibits osteoclastic activity and resorption of bone.</u></em></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223df773dd2-ca72-4513-8405-6d41bb14619b.jpg\">\r\n<p><strong><em>Denosumab</em></strong></p>\r\n<ul>\r\n<li><em>It is a <u>fully human monoclonal antibody against RANKL</u>.</em></li>\r\n<li><em>By <u>binding to and neutralizing RANKL, denosumab prevents RANK activation, thereby inhibiting proliferation and differentiation of osteoclast precursors as well as osteoclast function.</u></em></li>\r\n<li><em>As a result, bone resorption is inhibited to an extent equal to or greater than potent BPNs.</em></li>\r\n<li><em>It is now being used as a <u>treatment option for osteoporosis in both women and Men as well as to limit bony metastasis in breast and prostate cancers.</u></em></li>\r\n<li><em>It can be given to patients with severe renal disease, in whom BPNs are contraindicated.</em></li>\r\n</ul>\r\n<p><strong><em>Adverse effects of denosumab </em></strong></p>\r\n<ul>\r\n<li><em>Flu-like symptoms, </em></li>\r\n<li><em>Initial fall in serum ca<sup>2+</sup> level</em></li>\r\n<li><em>Dermatitis</em></li>\r\n<li><em>Susceptibility to infections </em></li>\r\n<li><em>Osteonecrosis of the jaw (rarely)</em></li>\r\n</ul>\r\n<p><strong>Option A &amp; B</strong>: <em>Both of them are <strong>not antibody based treatment </strong>for osteoporosis.</em></p>\r\n<p><strong>Option D</strong>: <em>Infliximab is an <strong>Anti&ndash;TNF-&alpha;</strong> drug used in rheumatoid arthritis and Crohn&rsquo;s disease. </em></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Denosumab is a monoclonal antibody against RANK ligands. It inhibits osteoclastic activity and resorption of bone.</em></li>\r\n</ul>",
      "correct_choice_id": 223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibition of osteoclast activity</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulation of osteoblast activity</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulation of renal calcium reabsorption</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulation of renal phosphate reabsorption</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 51-year-old woman, recently diagnosed with Paget's disease of bone, had been receiving alendronate for 1 week, but the drug had to be suspended because of a persistent abdominal pain. The physician decided to replace the alendronate with calcitonin. Which of the following actions most likely mediated the therapeutic effect of calcitonin in the patient's disease?</span></p>",
      "unique_key": "DT1293470",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293470,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em>Calcitonin is a hormone secreted by the parafollicular cells of the thyroid. </em></p>\r\n<p><em><u>The principal action of the hormone is a direct inhibition of osteoclastic bone resorption</u></em><em>. </em></p>\r\n<p><em>This action is mediated by the activation of calcitonin receptors located on osteoclasts, which in turn causes a profound decrease in the rugged border of these cells, thereby inhibiting bone resorption.</em></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223e2a37b21-af8f-4a23-a177-6515e17a0d1e.jpg\">\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>The principal action of the Calcitonin hormone is a direct inhibition of osteoclastic bone resorption.</em></li>\r\n</ul>\r\n<p>Option B: Teriparatide only causes Osteoblast stimulation.</p>\r\n<p>Option C &amp; D : Calcitonin Reduces Calcium &amp; Phosphorus Reabsorption from kidney.</p>",
      "correct_choice_id": 231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Teriparatide</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Ethinyl estradiol</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Pamidronate</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitonin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 61-year-old woman suffering from osteoporosis had been receiving alendronate and vitamin D supplementation for 2 years. Recent dual-energy x-ray absorptiometry showed a big decrease in bone density. The patient's history was significant for a femur fracture 2 months earlier. Which of the following drugs is most likely to increase bone density in this patient?</span></p>",
      "unique_key": "DT1293473",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293473,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><em><u>Teriparatide is a recombinant analogue of parathyroid hormone (PTH) with physiological actions equal to those of the natural hormone</u></em><em>. </em></p>\r\n<p><em>PTH exerts <strong>both catabolic and anabolic effects on bone</strong>. </em></p>\r\n<ul>\r\n<li><strong><em>Catabolic effects</em></strong><em> prevail with <strong><u>chronically elevated PTH</u></strong>; there is a net increase in bone resorption. </em></li>\r\n<li><strong><em>Anabolic effects</em></strong><em> prevail with <strong><u>intermittent low doses of PTH</u>;</strong> there is a net <u>increase in bone formation (by increasing osteoblast number and activity) without stimulating bone resorption. </u></em></li>\r\n</ul>\r\n<p><em>The drug is reserved for advanced osteoporosis when bisphosphonate therapy has failed, extreme bone loss has already occurred, and/or fracture has already occurred, as in this case. </em></p>\r\n<p><em>Teriparatide is the only currently available therapy that results in net bone deposition.</em></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223ea1d2b40-3147-4684-9ea7-0fcb2fab3a15.jpg\">\r\n<p><strong>Option B, C &amp; D</strong>: <em>All of them work by inhibition of osteoclastic bone resorption. </em></p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li><em>Teriparatide is the only currently available therapy that results in net bone deposition by Osteoblast Stimulation.</em></li>\r\n</ul>",
      "correct_choice_id": 241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}